INDmoney
Halozyme Therapeutics, Inc. Stock Performance
as on February 3, 2026 at 2:29 am IST
Day's Low
Day's High
$71.39$74.46
4.14%
Downside
-0.01%
Upside
52 Week's Low
52 Week's High
$47.50$79.5036.22%
Downside
6.75%
Upside
Halozyme Therapeutics, Inc. share price movements today
- Previous Close
- $71.71
- Open
- $71.91
- Volume
- 1.5M
- Day's Low - High
- $71.39 - $74.46
- 52 Week Low - High
- $47.50 - $79.50
Halozyme Therapeutics, Inc. Historical Returns
- 1 Month Return
- + 1.99 %
- 3 Month Return
- + 10 %
- 1 Year Return
- + 26.61 %
- 3 Year Return
- + 35.63 %
- 5 Year Return
- + 45.04 %
Halozyme Therapeutics, Inc. Stock Fundamentals & Key Indicators
Check Halozyme Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$8.2B
EPS (TTM)
6.254
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.36%
PE Ratio (TTM)
14.74
Industry PE ratio
5.33235294117647
PEG Ratio
-2.5
EBITDA
813.3M
Revenue (TTM)
1.2B
Profit Margin
47.91%
Return On Equity TTM
124.50%
Halozyme Therapeutics, Inc. Stock Valuation
Track how Halozyme Therapeutics, Inc. P/E has moved over time to understand its valuation trends.
Halozyme Therapeutics, Inc. in the last 5 years
Lowest (10.98x)
June 30, 2025
Industry (5.33x)
February 2, 2026
Today (14.74x)
February 2, 2026
Highest (34.85x)
March 31, 2021
Today’s Price to Earnings Ratio: 14.74x
Halozyme Therapeutics, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Halozyme Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $8.2B | 45.04% | 14.74 | 47.91% | |
| BUY | $122.3B | 116.21% | 33.56 | 31.35% | |
| BUY | $47.7B | 119.45% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 48.3% | 18.28 | 32.13% |
Stock Returns calculator for Halozyme Therapeutics, Inc. Stock including INR - Dollar returns
The Halozyme Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Halozyme Therapeutics, Inc. investment value today
Current value as on today
₹1,36,672
Returns
₹36,672
(+36.67%)
Returns from Halozyme Therapeutics, Inc. Stock
₹31,480 (+31.48%)
Dollar Returns*
₹5,193 (+5.19%)
Analyst Recommendation on Halozyme Therapeutics, Inc. Stock
Based on 17 analysts
82.35%
Buy
17.65%
Hold
0.00%
Sell
Based on 17 analysts, 82.35% of analysts recommend a 'BUY' rating for Halozyme Therapeutics, Inc.. Average target price of $78
Halozyme Therapeutics, Inc. Share Price Target
Get share price movements and forecasts by analysts on Halozyme Therapeutics, Inc..
What analysts predicted
4.53%UPSIDE
Target Price
$78
Current Price
$74.47
Analyzed by
17 Analysts
Target
$78.00
Halozyme Therapeutics, Inc. target price $78, a slight upside of 4.53% compared to current price of $74.47. According to 17 analysts rating.
Halozyme Therapeutics, Inc. Stock’s Investor Sentiment and Interest
Search interest for Halozyme Therapeutics, Inc. Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Halozyme Therapeutics, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Halozyme Therapeutics, Inc. Annual Profit & Loss
All numbers in Millions USD
Halozyme Therapeutics, Inc. Quarterly Cash Flow
All numbers in Millions USD
Halozyme Therapeutics, Inc. Annual Cash Flow
All numbers in Millions USD
Halozyme Therapeutics, Inc. News & Key Events
Insights on Halozyme Therapeutics, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 264.86M → 354.26M (in $), with an average increase of 13.4% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 118.09M → 175.22M (in $), with an average increase of 17.1% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, HALO has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 7 days, HALO stock has moved up by 2.1%
NO EFFECTAgainst Peers
In the last 1 year, Beone Medicines Ltd has given 52.4% return, outperforming this stock by 25.0%
About Halozyme Therapeutics, Inc.
| Organisation | Halozyme Therapeutics, Inc. |
| Headquarters | 12390 El Camino Real, San Diego, CA, United States, 92130 |
| Industry | Health Technology |
| CEO | Dr. Helen I. Torley M.B. Ch. B., M.R.C.P. |
| E-voting on shares | Click here to vote |
Key Management of Halozyme Therapeutics, Inc.
Name | Title |
|---|---|
Ms. Nicole LaBrosse CPA | Senior VP & CFO |
Ms. Cortney Caudill M.B.A. | Senior VP & COO |
Ms. Tram Bui | Head of Investor Relations & Corporate Communications |
Dr. Christopher Wahl M.B.A., M.D. | Chief Scientific Officer |
Dr. Charles P. Theuer M.D., Ph.D. | Chief Medical Officer |
Dr. Helen I. Torley M.B. Ch. B., M.R.C.P. | President, CEO & Director |
Mr. Mark Snyder Esq. | Senior VP, General Counsel, Chief Compliance Officer & nd Secretary |
Mr. Paul Spence | Chief Commercial Officer |
Mr. Rhys de Callier | Chief Strategy Officer |
Mr. Chase Coffman Ph.D. | President of Hypercon |
FAQs
What is Halozyme Therapeutics, Inc. share price today?
Halozyme Therapeutics, Inc. share price today is $74.47 as on at the close of the market. Halozyme Therapeutics, Inc. share today touched a day high of $74.46 and a low of $71.39.
What is the 52 week high and 52 week low for Halozyme Therapeutics, Inc. share?
Halozyme Therapeutics, Inc. share touched a 52 week high of $79.5 on and a 52 week low of $47.5 on . Halozyme Therapeutics, Inc. stock price today i.e. is closed at $74.47,which is 6.33% down from its 52 week high and 56.78% up from its 52 week low.
What is Halozyme Therapeutics, Inc.'s market capitalisation today?
Halozyme Therapeutics, Inc. market capitalisation is $0.01T as on .
How to invest in Halozyme Therapeutics, Inc. Stock (HALO) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Halozyme Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Halozyme Therapeutics, Inc. Shares that will get you 0.0201 shares as per Halozyme Therapeutics, Inc. share price of $74.47 per share as on February 3, 2026 at 2:29 am IST.
What is the minimum amount required to buy Halozyme Therapeutics, Inc. Stock (HALO) from India?
Indian investors can start investing in Halozyme Therapeutics, Inc. (HALO) shares with as little as ₹91.486 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹914.86 in Halozyme Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Halozyme Therapeutics, Inc. share’s latest price of $74.47 as on February 3, 2026 at 2:29 am IST, you will get 0.1343 shares of Halozyme Therapeutics, Inc.. Learn more about
fractional shares .
What are the returns that Halozyme Therapeutics, Inc. has given to Indian investors in the last 5 years?
Halozyme Therapeutics, Inc. stock has given 45.04% share price returns and 25.75% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?